Exploring the benefits, harms and costs of genomic newborn screening for rare diseases

Nat Med. 2024 Jul;30(7):1823-1825. doi: 10.1038/s41591-024-03055-x.
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Genetic Testing / economics
  • Genomics* / economics
  • Humans
  • Infant, Newborn
  • Neonatal Screening* / economics
  • Rare Diseases* / diagnosis
  • Rare Diseases* / genetics